Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It develops and commercializes next-generation abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases.
| Website: | www.collegiumpharma.com |
| Main Phone: | +1 781 713-3699 |
| Address: | 780 Dedham Street |
| Address 2: | Suite 800 |
| State: | MA |
| City / Town: | Canton |
| Country: | USA |
| Postal Code: | 02021 |
| Exchange: | NGS |
| Employees: | 46 |
| NAICS: | Pharmaceutical P |
| Last Price 10.31 | Change $ 0.25 | Change % 2.49 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 10.07 | High 10.36 | Low 9.94 | Prev Close 10.06 |
| Last Trade | Volume 256,806 | 52 Wk Hi 20.55 | 52 Wk Low 7.37 |
| Market Cap 304.8 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 29,566,975.00 | EPS (TTM) -3.67 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 3 | 13 |
| Number of Buys | 3 | 13 |
| Number of Sells | 0 | 0 |
| Net Activity | 3173 | 49738 |
| Last 10 Buys | Shares |
|---|---|
| David Hirsch | 1,000 |
| David Hirsch | 1,000 |
| John G. Freund | 1,000 |
| James G. Coulter | 1,000 |
| Patrick G. Enright | 1,000 |
| Patrick G. Enright | 1,000 |
| Alan D. Frazier | 1,000 |
| Patrick J. Heron | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 32 | 32 | 39 | 32 |
| Low Target Price Estimate | 25 | 25 | 25 | 23 |
| Mean Target Price Estimate | 27.75 | 27.75 | 29.5 | 26.75 |
| Standard Deviation | 2.99 | 2.99 | 6.4 | 3.86 |
| Date of Most Recent Estimate | 08/12/16 | 08/11/16 | 07/22/16 | 08/19/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-15 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 116 | 2016-08-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 12 | 2016-08-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-13 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 |
| Moderate Buy | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1.2 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
